130 filings
Page 4 of 7
6-K
f5vl49d1blw3s8oc
28 May 21
Current report (foreign)
4:07pm
6-K
r6qbg6
30 Apr 21
Mereo BioPharma and Cancer Focus Fund Announce Partnership for Phase 1b/2 Study of Etigilimab in Clear Cell Ovarian Cancer
4:05pm
6-K
ww9a8g0upywzsm0mcrr
16 Apr 21
Current report (foreign)
4:10pm
6-K
lww mt2w06txq
31 Mar 21
Mereo BioPharma Reports Full Year 2020 Financial Results and Recent Highlights
5:13pm
6-K
sgq n0a1odbrqvapwk
12 Feb 21
Current report (foreign)
4:06pm
6-K
o7mmp
10 Feb 21
Mereo BioPharma Group plc Announces Proposed Public Offering of American Depositary Shares
5:23pm
6-K
jyta5
1 Feb 21
Current report (foreign)
5:06pm
6-K
6bmsy
14 Jan 21
Current report (foreign)
7:06am
6-K
swjyi0q ufcfpm
17 Dec 20
Mereo BioPharma and Ultragenyx Announce Collaboration and License
5:16pm
6-K
ir61o 875stkuj
15 Dec 20
Current report (foreign)
2:22pm
6-K
c9s3op2sa8 bv
16 Nov 20
Current report (foreign)
7:27am
6-K
2gsbv
12 Nov 20
Current report (foreign)
6:15am
6-K
7yb6p2qonhq9 47
20 Oct 20
Mereo BioPharma Appoints Christine Fox as Chief Financial Officer and Heidi Petersen as Senior Vice President, Regulatory Affairs
7:12am
6-K
qm881o4v
19 Oct 20
Current report (foreign)
8:10am
6-K
ds3rar5rc8
13 Oct 20
Current report (foreign)
8:00am
6-K
emmum noazqjx
9 Oct 20
Current report (foreign)
4:05pm
6-K
jxdatqnhmsz
7 Oct 20
Mereo BioPharma Files Registration Statement on Form F-3 with U.S. Securities and Exchange Commission
9:53am
6-K
k2xjwecx58ar 94f26uo
1 Oct 20
Current report (foreign)
4:30pm
6-K
1cirnbsc 8l1u2
29 Sep 20
Current report (foreign)
7:08am
6-K
jdu41
28 Sep 20
Result of General Meeting
4:43pm